<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>13(4)</volume><submitter>Li J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>In China, esophageal squamous cell carcinoma (ESCC) accounts for more than 90% of all esophageal cancer cases. Interleukin 13 (IL-13) was widely reported to play a key role in tumor progression. Our previous study reported that IL-13 was a favorable predictive marker for the overall survival of esophageal squamous cell carcinoma (ESCC) patients, but how IL-13 contributes to ESCC progression remains unknown. This study aims to explore the role of IL-13 and its underlying downstream molecular mechanisms in ESCC progression.&lt;h4>Methods&lt;/h4>Tissue microarrays including 262 primary ESCC tumor tissues were collected and analyzed. The expression of IL-13 in ESCC tumor tissue was detected with immunohistochemistry staining (IHC). Quantitative real-time polymerase chain reaction </pubmed_abstract><journal>Journal of gastrointestinal oncology</journal><pagination>1571-1578</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9459211</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells.</pubmed_title><pmcid>PMC9459211</pmcid><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Shao J</pubmed_authors><pubmed_authors>Guo Y</pubmed_authors><pubmed_authors>Guan X</pubmed_authors><pubmed_authors>Fang W</pubmed_authors><pubmed_authors>Duan C</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Lin J</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Wang K</pubmed_authors><pubmed_authors>Ma G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Interleukin 13 participates in terminal differentiation of esophageal squamous cell carcinoma cells.</name><description>&lt;h4>Background&lt;/h4>In China, esophageal squamous cell carcinoma (ESCC) accounts for more than 90% of all esophageal cancer cases. Interleukin 13 (IL-13) was widely reported to play a key role in tumor progression. Our previous study reported that IL-13 was a favorable predictive marker for the overall survival of esophageal squamous cell carcinoma (ESCC) patients, but how IL-13 contributes to ESCC progression remains unknown. This study aims to explore the role of IL-13 and its underlying downstream molecular mechanisms in ESCC progression.&lt;h4>Methods&lt;/h4>Tissue microarrays including 262 primary ESCC tumor tissues were collected and analyzed. The expression of IL-13 in ESCC tumor tissue was detected with immunohistochemistry staining (IHC). Quantitative real-time polymerase chain reaction </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-19T18:29:27.007Z</modification><creation>2025-04-19T18:29:27.007Z</creation></dates><accession>S-EPMC9459211</accession><cross_references><pubmed>36092316</pubmed><doi>10.21037/jgo-22-559</doi></cross_references></HashMap>